Market Cap 20.49M
Revenue (ttm) 8.01M
Net Income (ttm) -7.13M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -89.01%
Debt to Equity Ratio 0.00
Volume 5,700
Avg Vol 51,322
Day's Range N/A - N/A
Shares Out 5.64M
Stochastic %K 15%
Beta 1.21
Analysts Strong Sell
Price Target $15.00

Company Profile

Vyome Holdings Inc., a clinical-stage healthcare company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States and global markets. The company was founded in 2017 and is based in Cambridge, Massachusetts.

Industry: Biotechnology
Sector: Healthcare
Phone: 973-832-8147
Address:
Harvard Square, One Mifflin Place Suite 400, Cambridge, United States
OlindoFL
OlindoFL Dec. 24 at 3:40 PM
$HIND LOL that there are still Sunshine Pumpers for this steaming turd! 💩
0 · Reply
DARKP00L
DARKP00L Dec. 22 at 1:10 PM
$HIND 08:06 on Dec. 22 2025 Vyome Holdings Subsidiary, LiveChain, To Acquire Senior Secured Note In Humanyze; LiveChain To Issue Shares Of ~$325K In Exchanve #tradeideas
0 · Reply
Stock_Catcher
Stock_Catcher Dec. 22 at 1:00 PM
$HIND Vyome Subsidiary LiveChain (LICH) to Acquire Senior Secured Note in Humanyze, An MIT Incubated Company
0 · Reply
HumanityFirst
HumanityFirst Dec. 17 at 2:29 AM
$HIND anyone who was involved in this scam against retail investors - see you in court.
1 · Reply
HumanityFirst
HumanityFirst Dec. 10 at 4:33 AM
$HIND The asset sale was a major fraud against investors.
1 · Reply
Shane393
Shane393 Dec. 9 at 7:36 PM
$HIND what a fukin scam Reshape 2.0
0 · Reply
Fl1p_M0p_GaZ
Fl1p_M0p_GaZ Dec. 9 at 3:18 PM
$HIND When I see Next NRG holding this $7M+ monthly zone and stacking triple-digit YoY rates while Q3 already hit $22.9M up 232% YoY, I think the long-term multiple expansion story becomes more plausible with each new update 🚀
0 · Reply
tWiStY_JaMbOx
tWiStY_JaMbOx Dec. 9 at 3:18 PM
$HIND I’m stacking the Next NRG receipts not just the headline $7.51M November +271% YoY vs $2.02M on top of $7.39M October +196% vs $2.50M is the kind of 2-month combo that builds real long-term trust 🚀
0 · Reply
Shane393
Shane393 Dec. 8 at 10:48 PM
$HIND Vyome says "Huge step forward" these guys are desperate trading at 1/3 of what reshape was worth. Month pivots show this is going down more it simply popped a few cents above previous month value to take more victims here so short away.
0 · Reply
VyomeInc1
VyomeInc1 Dec. 8 at 7:14 PM
$HIND Huge step forward! Vyome reports positive final Phase 2 results for VT1953 for treating symptoms of malignant fungating wounds — a condition with no FDA-approved treatments today. ✔️ bad smell reduction - Primary endpoint met (strong significance) ✔️ Symptom improvements that matter to patients ✔️ Potential path toward Orphan Drug Designation ✔️ FDA interactions + pivotal study start in 2026 Clean structure. Strong team. Real progress. More ahead. #Biotech #ClinicalTrials #Inflammation
3 · Reply
Latest News on HIND
Vyome Holdings Acquires MIT AI Spinout Oculo Health

Sep 29, 2025, 7:00 AM EDT - 3 months ago

Vyome Holdings Acquires MIT AI Spinout Oculo Health


Vyome Announces Strategic Review of Livechain (OTCID: LICH)

Aug 18, 2025, 8:30 AM EDT - 4 months ago

Vyome Announces Strategic Review of Livechain (OTCID: LICH)


ReShape Lifesciences Announces 1-for-25 Reverse Stock Split

May 7, 2025, 8:31 AM EDT - 8 months ago

ReShape Lifesciences Announces 1-for-25 Reverse Stock Split

RSLS


ReShape Lifesciences Announces 1-for-58 Reverse Stock Split

Sep 19, 2024, 8:31 AM EDT - 1 year ago

ReShape Lifesciences Announces 1-for-58 Reverse Stock Split

RSLS


OlindoFL
OlindoFL Dec. 24 at 3:40 PM
$HIND LOL that there are still Sunshine Pumpers for this steaming turd! 💩
0 · Reply
DARKP00L
DARKP00L Dec. 22 at 1:10 PM
$HIND 08:06 on Dec. 22 2025 Vyome Holdings Subsidiary, LiveChain, To Acquire Senior Secured Note In Humanyze; LiveChain To Issue Shares Of ~$325K In Exchanve #tradeideas
0 · Reply
Stock_Catcher
Stock_Catcher Dec. 22 at 1:00 PM
$HIND Vyome Subsidiary LiveChain (LICH) to Acquire Senior Secured Note in Humanyze, An MIT Incubated Company
0 · Reply
HumanityFirst
HumanityFirst Dec. 17 at 2:29 AM
$HIND anyone who was involved in this scam against retail investors - see you in court.
1 · Reply
HumanityFirst
HumanityFirst Dec. 10 at 4:33 AM
$HIND The asset sale was a major fraud against investors.
1 · Reply
Shane393
Shane393 Dec. 9 at 7:36 PM
$HIND what a fukin scam Reshape 2.0
0 · Reply
Fl1p_M0p_GaZ
Fl1p_M0p_GaZ Dec. 9 at 3:18 PM
$HIND When I see Next NRG holding this $7M+ monthly zone and stacking triple-digit YoY rates while Q3 already hit $22.9M up 232% YoY, I think the long-term multiple expansion story becomes more plausible with each new update 🚀
0 · Reply
tWiStY_JaMbOx
tWiStY_JaMbOx Dec. 9 at 3:18 PM
$HIND I’m stacking the Next NRG receipts not just the headline $7.51M November +271% YoY vs $2.02M on top of $7.39M October +196% vs $2.50M is the kind of 2-month combo that builds real long-term trust 🚀
0 · Reply
Shane393
Shane393 Dec. 8 at 10:48 PM
$HIND Vyome says "Huge step forward" these guys are desperate trading at 1/3 of what reshape was worth. Month pivots show this is going down more it simply popped a few cents above previous month value to take more victims here so short away.
0 · Reply
VyomeInc1
VyomeInc1 Dec. 8 at 7:14 PM
$HIND Huge step forward! Vyome reports positive final Phase 2 results for VT1953 for treating symptoms of malignant fungating wounds — a condition with no FDA-approved treatments today. ✔️ bad smell reduction - Primary endpoint met (strong significance) ✔️ Symptom improvements that matter to patients ✔️ Potential path toward Orphan Drug Designation ✔️ FDA interactions + pivotal study start in 2026 Clean structure. Strong team. Real progress. More ahead. #Biotech #ClinicalTrials #Inflammation
3 · Reply
fredbull
fredbull Dec. 8 at 6:26 PM
$HIND this could next. Greta news today. Heavy loading . All in
0 · Reply
www_larval_com
www_larval_com Dec. 8 at 5:28 PM
Dumbo reporting in! $HIND has popped 8% higher to 12% (~536Kv) moments ago, follow for more volatility.
0 · Reply
MasterOfMyDomains
MasterOfMyDomains Dec. 8 at 1:15 PM
$HIND Doomed to fail. Everyone short it so you can make money, otherwise, fuck them all.
0 · Reply
54486JKO
54486JKO Dec. 8 at 1:14 PM
$HIND The stock dropped mainly due to sell the news’reaction. While Phase 2 results showed statistical improvements, most data were secondary/exploratory endpoints and short-term (14 days). Investors expected stronger primary endpoint data and near-term catalysts. The long timeline to Phase 3 (2026) and potential dilution risk also pressured the stock
0 · Reply
DaBullRunner
DaBullRunner Dec. 8 at 1:11 PM
$FMST there it goes… Back to $300+ 🚨LRHC🚨this is my next one and I want $2-5 🎯✅ $1.5 BILLION ✅ TINY FLOAT ✅ $HIND $GNLN $JFBR $TWG what a morning
0 · Reply
Love_To_Learn
Love_To_Learn Dec. 8 at 1:10 PM
$HIND shifted internal shares off the pop just now rebuilding market channel linkage off the 6-7 pt 4 others
0 · Reply
Love_To_Learn
Love_To_Learn Dec. 8 at 1:09 PM
$HIND changing the algo
0 · Reply
Love_To_Learn
Love_To_Learn Dec. 8 at 1:09 PM
$HIND manipulating u !
0 · Reply
54486JKO
54486JKO Dec. 8 at 1:08 PM
$HIND I've been bitten by a stock FUCK!
0 · Reply
MasterOfMyDomains
MasterOfMyDomains Dec. 8 at 1:04 PM
$HIND can we get 100%?
0 · Reply
Stock_Catcher
Stock_Catcher Dec. 8 at 1:00 PM
$HIND Vyome Reports Positive Final Phase 2 Results for VT-1953; Plans to Advance Into Pivotal Study For FDA Approval
0 · Reply
saudq1978
saudq1978 Dec. 3 at 11:09 PM
$HIND $SPY 55 basis points. NOT AGAIN MAN!
0 · Reply